CD14 and type 2 diabetes mellitus: To determine whether our observations could reflect the state of in vivo circulating monocytes, we next evaluated the cell surface expression of TLR4 and CD14 co-receptors in PBMC from 28 subjects without diabetes and 25 subjects with T2D, as well as their association with subclinical atherosclerosis (Figure 6).